You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Correspondence Would You Save This Patient’s Eye or His Brain?
Nitin K. Sethi; Josh Torgovnick; Prahlad K. Sethi; Edward Arsura
Arch Neurol 2009; 66: 1178.
[Extract][Full text][PDF]
Past content
(since May 1998):
Clinical Trials Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009; 66: 563-570.
[Abstract][Full text][PDF]
Clinical Trials Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009.32.
[Abstract][Full text][]
Original Contributions High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Douglas E. Gladstone; Kenneth W. Zamkoff; Lauren Krupp; Robert Peyster; Patrick Sibony; Christopher Christodoulou; Emily Locher; Patricia K. Coyle
Arch Neurol 2006; 63: 1388-1393.
[Abstract][Full text][PDF]
Original Contributions High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Douglas E. Gladstone; Kenneth W. Zamkoff; Lauren Krupp; Robert Peyster; Patrick Sibony; Christopher Christodoulou; Emily Locher; Patricia K. Coyle
Arch Neurol 63.10.noc60076.
[Abstract][Full text][]
Original Contributions Subthalamic Stimulation in Parkinson Disease: Behavior and Social Adaptation
Jean-Luc Houeto; Luc Mallet; Valérie Mesnage; Sophie Tezenas du Montcel; Cécile Béhar; Marcela Gargiulo; Frederic Torny; Antoine Pelissolo; Marie-Laure Welter; Yves Agid
Arch Neurol 2006; 63: 1090-1095.
[Abstract][Full text][PDF]
Original Contributions Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life
Kristine Yaffe; Eric Vittinghoff; Kristine E. Ensrud; Karen C. Johnson; Susan Diem; Vladimir Hanes; Deborah Grady
Arch Neurol 2006; 63: 945-950.
[Abstract][Full text][PDF]
Correspondence Quality of Life Is Not Favorable for Most Patients With Multiple Sclerosis
Alex J. Mitchell; Julían Benito-León; Jesús Rivera-Navarro; José Manuel Morales-González
Arch Neurol 2004; 61: 1807-a-1808-a.
[Extract][Full text][PDF]
Correspondence Adaptation Is Favorable for Most Patients With Multiple Sclerosis
